XML 45 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended
Mar. 30, 2014
Mar. 31, 2013
Income Statement [Abstract]    
Revenues $ 15,285 $ 21,019
Cost of products sold 10,950 14,640
Gross profit 4,335 6,379
Operating expenses:    
Research and development 1,436 1,369
Selling, general and administrative 3,995 4,635
Total operating expenses 5,431 6,004
Operating (loss) income (1,096) 375
Other (expense) income:    
Interest income 9 2
Interest and financing expense (56) (90)
Miscellaneous (16) (25)
(Loss) income from continuing operations before income taxes (1,159) 262
Income tax provision (60) (98)
Net (loss) income from continuing operations (1,219) 164
Income (loss) from discontinued operations, net of tax 61 (264)
Net (loss) income (1,280) 428
Net (income) loss attributable to noncontrolling interest (6) 6
Net (loss) income attributable to Ultralife (1,286) 434
Other comprehensive income:    
Foreign currency translation adjustments 66 (127)
Comprehensive (loss) income attributable to Ultralife $ (1,220) $ 307
Net (loss) income per share attributable to Ultralife common shareholders - Basic:    
Continuing operations (in dollars per share) $ (0.07) $ 0.01
Discontinued operations (in dollars per share) $ 0.00 $ 0.02
Total (in dollars per share) $ (0.07) $ 0.02
Net income per share attributable to Ultralife common shareholders - Diluted:    
Continuing operations (in dollars per share)   $ 0.01
Discontinued operations (in dollars per share)   $ 0.02
Total (in dollars per share)   $ 0.02
Weighted average shares outstanding - basic 17,513 17,457
Potential common shares   21
Weighted average shares outstanding - diluted   17,478